The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
The Food and Drug Administration (FDA) has granted 510(k) clearance to the artificial intelligence (AI)-powered CINA-ASPECTS, which may enhance the evaluation of stroke severity, and the AI-enabled CINA-IPE, which is geared toward bolstering the detection of incidental pulmonary embolism (PE).
Based off brain non-contrast computed tomography (NCCT) images, the CINA-ASPECTS modality provides heat mapping probabilities of sulcal effacement and hypodensity, identifies infarcted regions and offers automated ASPECT scoring for stroke severity, according to Avicenna.AI, the developer of CINA-ASPECTS.
"The validations and multi-reader-multi-case studies we conducted highlighted that CINA-ASPECTS not only obtained outstanding standalone performance, but also demonstrated that its adjunctive use significantly improved clinicians' accuracy in the assessment of ASPECTS regions, compared to the conventional use of NCCT images alone," added Yasmina Chaibi, a clinical affairs manager for Avicenna.AI.
Avicenna.AI said the CINA-iPE modality, reportedly validated on 381 CT scans from 39 different CT scanner models, may facilitate timely triage with its strong sensitivity and specificity for the diagnosis of incidental PE.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.